TNF and rheumatoid arthritis: A recent study showed that the outcome of RA patients on baricitinib was comparable to or better than TNF inhibitors, and suggested that RA patients who failed to respond to cDMARDs, are recommended to start baricitinib which is a feasible alternative to TNF inhibitors [41].